Asker Healthcare Group AB has announced a notable increase in its turnover and EBITDA, achieving a growth rate of 10.52%. This positive development comes at a time when broader market sentiment is marked by extreme fear, as indicated by recent volatility and declining investor confidence. Despite the challenging macroeconomic environment, characterized by a slight decline in return on capital over the past three months, Asker's performance stands out. The healthcare sector often exhibits resilience during downturns, and Asker's growth may reflect a robust demand for its services. Investors will be keen to see if this momentum can be sustained as the company navigates through prevailing economic uncertainties.